Biomedix Incubator Stock Return On Equity
| BMDX Stock | ILS 19,060 240.00 1.28% |
Biomedix Incubator fundamentals help investors to digest information that contributes to Biomedix Incubator's financial success or failures. It also enables traders to predict the movement of Biomedix Stock. The fundamental analysis module provides a way to measure Biomedix Incubator's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biomedix Incubator stock.
Biomedix |
Biomedix Incubator Company Return On Equity Analysis
Biomedix Incubator's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Biomedix Incubator Return On Equity | -21.76 |
Most of Biomedix Incubator's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biomedix Incubator is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Biomedix Incubator has a Return On Equity of -21.76. This is much lower than that of the sector and significantly lower than that of the Return On Equity industry. The return on equity for all Israel stocks is notably higher than that of the company.
Biomedix Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biomedix Incubator's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biomedix Incubator could also be used in its relative valuation, which is a method of valuing Biomedix Incubator by comparing valuation metrics of similar companies.Biomedix Incubator is currently under evaluation in return on equity category among its peers.
Biomedix Fundamentals
| Return On Equity | -21.76 | |||
| Return On Asset | -14.0 | |||
| Current Valuation | 14.72 M | |||
| Shares Outstanding | 2.07 M | |||
| Price To Earning | (545.45) X | |||
| Price To Book | 361.86 X | |||
| Revenue | 2 K | |||
| Gross Profit | (39 K) | |||
| EBITDA | (1.46 M) | |||
| Net Income | (1.36 M) | |||
| Cash And Equivalents | 5.71 M | |||
| Cash Per Share | 5.10 X | |||
| Current Ratio | 30.06 X | |||
| Book Value Per Share | 4.98 X | |||
| Cash Flow From Operations | (1.62 M) | |||
| Earnings Per Share | (1.10) X | |||
| Beta | 1.21 | |||
| Market Capitalization | 37.28 M | |||
| Total Asset | 9 M | |||
| Retained Earnings | (181 M) | |||
| Working Capital | 9 M | |||
| Current Asset | 9 M | |||
| Z Score | -26.8 |
About Biomedix Incubator Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biomedix Incubator's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomedix Incubator using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomedix Incubator based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biomedix Stock
Biomedix Incubator financial ratios help investors to determine whether Biomedix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biomedix with respect to the benefits of owning Biomedix Incubator security.